ANTI-MICROBIAL INFUSIONS
CIPROXOL
CIPROXOL 100mL solution contains 254mg of Ciprofloxacin Lactate equivalent to 200mg of Ciprofloxacin in Sodium Chloride 0.9%w/v.
| Brand Name | CIPROXOL |
| Description | Ciprofloxacin 0.2% w/v Intravenous Infusion BP |
| Packaging | Bottle |
Packaging
| No | Brand Name | Description | Packaging/Size |
| Bottle (mL) | |||
| 1 | CIPROXOL | Ciprofloxacin 0.2% w/v Intravenous Infusion BP |
100 |
Indications
Treatment of the following infections caused by organism strains:
- Lower Respiratory Tract Infections caused by Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis and Pseudomonas aeruginosa.
- Urinary Tract Infections caused by Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis, Providencia rettgeri, Morganella morganii, Citrobacter freundii, Citrobacter diversus and Pseudomonas aeruginosa.
- Skin And Soft Tissue Infections caused by Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis, Proteus vulgaris, Providencia Stuartii, Morganella morganii, Citrobacter freundii, Pseudomonas aeruginosa, Staphylococcus aereus and Staphylococcus epidermidis (methicilin - resistant strains). In the last case, concomitant treatment with another antibiotic is suggested, in order to prevent organism resistance to ciprofloxacin.
- Gastrointestinal Tract Infections caused by mutiresistant gram-negative organisms, in combination with an antibiotic against anaerobes.
- Bone and Joint Infections caused by Enterobacter aeruginosa, Serratia marcescens, Pseudomonas aeruginosa, and Enterobacter spp. in general.
- Other severe / complicated infections, patients with sepsis or neutropenia, Ps. Aeriginosa infections.